ED Care ComparisonExpert analysis updated June 2026

BraveRx vs MEDVi: ED Treatment Comparison (2026)

BraveRx and MEDVi both offer fast-acting ED treatment through telehealth. BraveRx provides a 3-in-1 oral dissolving tablet (Tadalafil 15mg + Apomorphine 3mg + Sildenafil 40mg) at $159/bottle. MEDVi differentiates with its 4-in-1 sublingual liquid formula combining four active ingredients for potentially faster onset.

Our Verdict

There is no single winner here, it depends on your priorities. BraveRX suits men who want a focused 3-in-1 oral dissolving tablet with Apomorphine at a transparent per-bottle price. MEDVi suits men who want the fastest sublingual onset and a four-ingredient approach.

Side-by-Side Feature Comparison

Feature	BraveRx	MEDVi	Winner
Formula Type	3-in-1 (Tadalafil + Apomorphine + Sildenafil)	4-in-1 (Vardenafil + Sildenafil + Tadalafil + Apomorphine)	MEDVi
Delivery Method	Oral dissolving tablet	Sublingual liquid (under tongue)	MEDVi
Onset Time	~15 minutes	10-15 minutes	Tie
Duration	Up to 36 hours	36-hour coverage	Tie
Price	$159 per bottle (12 count)	$114 (5-pack) / $179 (10-pack)	Tie
State Availability	Varies by state	Varies by state	Tie

Pros and Cons

BraveRx

Pros

3-in-1 formula with Apomorphine for neurological arousal
Long-lasting 36-hour effect
Oral dissolving tablet, convenient format
Transparent $159/bottle pricing

Cons

Fewer ingredients vs. MEDVi 4-in-1
Not available in every U.S. state

Best For

Men who want a focused 3-in-1 oral dissolving tablet with Apomorphine at a transparent per-bottle price.

Read BraveRx Review

MEDVi

Pros

4-in-1 formula for enhanced coverage
Sublingual liquid for faster absorption
Addresses desire, firmness, onset, and duration
Single dose with extended coverage

Cons

Liquid sublingual format may not suit everyone
Monthly subscription pricing

Best For

Men who want maximum onset speed and a comprehensive four-ingredient formula.

Read MEDVi Review

Frequently Asked Questions: BraveRx vs MEDVi

BraveRX's 3-in-1 combination of Tadalafil, Apomorphine, and Sildenafil offers broader coverage than single-ingredient options by targeting both blood flow and neurological arousal pathways simultaneously.

Sublingual liquids (MEDVi) may absorb slightly faster than oral dissolving tablets (BraveRX), though both target onset within 15 minutes. BraveRX reports effects in as little as 15 minutes.

BraveRX is priced at $159 per bottle (12 count). MEDVi QUAD is priced at $114 for a 5-pack and $179 for a 10-pack. Compare based on your usage frequency to determine the better value.

Full Review

BraveRx

Full Review

MEDVi

ED Care Guides

Online ED Treatment: How Telehealth Prescriptions Work

Understanding the online consultation process, prescription requirements, and medication delivery for ED care through licensed telehealth providers.

Sildenafil vs Tadalafil: Choosing the Right ED Medication

A practical, evidence-based comparison of the two most widely prescribed ED medications to help you make an informed treatment decision.

ED Causes and When to See a Doctor

A clear overview of the physical and psychological causes of erectile dysfunction, what symptoms warrant prompt medical evaluation, and when telehealth is appropriate.

Compare All ED Care Providers

See the full ranked list of ed care providers side-by-side with ratings and pricing.

View All Providers

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.

Editorial Standards: Independent research · Evidence-based analysis · Transparent methodology · 2026